List view / Grid view
Dolomite Bio is delighted to announce the launch of the game-changing Nadia single cell platform, a groundbreaking system set to escalate scRNA-Seq to new heights, offering the fast-growing single cell research sector an innovative solution for a wide range of potential applications...
Genes linked to schizophrenia in psychiatric patients suffering from bipolar disorder are the reason why such patients don't respond to the drug lithium...
The effect of combining clinically used drugs for the treatment of colon cancer analysed using novel open source software...
At 4:00 pm on Thursday the 2nd of November, Lab Innovations celebrated the end of another extremely successful show at the NEC, Birmingham, UK, involving over 130 exhibitors and over 2,500 visitors...
The MicroTAS Video Competition 2017, sponsored by Dolomite Microfluidics and Lab on a Chip, and supported by the Chemical and Biological Microsystems Society, saw first prize awarded to Anu Kaushik and Alex Trick, PhD candidates in the BioMEMS and Single Molecule Dynamics Lab at Johns Hopkins University in Baltimore, Maryland...
A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the rate of decline in kidney function in patients with polycystic kidney disease...
The FDA has expanded the approval of Zelboraf to include the treatment of certain adult patients with Erdheim-Chester Disease, a rare cancer of the blood...
Special bandages that use weak electric fields to disrupt bacterial biofilm infection can prevent infections, combat antibiotic resistance and enable wound healing...
A study has provided strong evidence that certain carbon nanotubes used in manufacturing could pose the same cancer risk as asbestos...
Researchers have developed a new drug screening technique that could lead to the rapid and accurate identification of drugs...
FDA approves Vimpat for partial-onset seizures in paediatric epilepsy patients as an oral solution or a convenient tablet...
Tomography coronary angiography used to assess the presence of atherosclerosis associated with anabolic androgenic steroid abuse...
The FDA has approved a New Drug Application for Vyzulta for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension....
A vaccine combining centralised ancestral genes from four major influenza strains appears to provide broad protection against influenza...
BASF Corporation and DIEM Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD)...
